BIOQUAL, a Rockville-based biotech firm, announced Tuesday that it has begun in-vivo testing of coronavirus COVID-19 vaccines. The company, founded in 1981, said that it has been developing animal models for a vaccine since February in partnership with Dr. Dan Barouch at Beth Israel Deaconess Medical Center, and the Ragon Institute, both affiliated with Harvard Medical School.
BIOQUAL has previously been active in vaccine development against AIDS, Hepatitis, Zika, and Chikungunya, to name a few. The firm is located at 9600 Medical Center Drive.
No comments:
Post a Comment